Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
Authors
Keywords
-
Journal
OncoImmunology
Volume 1, Issue 5, Pages 649-658
Publisher
Informa UK Limited
Online
2012-06-19
DOI
10.4161/onci.20365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10–producing suppressive CD4+T cells
- (2012) Dapeng Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nanostructured, Self-Assembling Peptide K5 Blocks TNF-αand PGE2Production by Suppression of the AP-1/p38 Pathway
- (2012) Woo Seok Yang et al. MEDIATORS OF INFLAMMATION
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
- Signal Transducer and Activator of Transcription 3 (Stat3C) Promotes Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Lung Tumorigenesis
- (2011) Lingyan Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- TLR4 Engagement during TLR3-Induced Proinflammatory Signaling in Dendritic Cells Promotes IL-10-Mediated Suppression of Antitumor Immunity
- (2011) D. Bogunovic et al. CANCER RESEARCH
- ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
- (2011) Maria Soledad Sosa et al. CLINICAL CANCER RESEARCH
- Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34+precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition
- (2011) Hester van Cruijsen et al. Immunotherapy
- The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease
- (2011) Ya Jing FENG et al. Journal of Digestive Diseases
- The aromatic volatile organic compounds toluene, benzene and styrene induce COX-2 and prostaglandins in human lung epithelial cells via oxidative stress and p38 MAPK activation
- (2011) Iljana Mögel et al. TOXICOLOGY
- MAP kinase p38 and its relation to T cell anergy and suppressor function of regulatory T cells
- (2010) Henric S. Adler et al. CELL CYCLE
- MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma
- (2010) Jing Lu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs
- (2010) Hedi Harizi et al. IMMUNOLOGY AND CELL BIOLOGY
- Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity
- (2010) Jelle J Lindenberg et al. Immunotherapy
- The Regulation of Th1 Responses by the p38 MAPK
- (2010) Z. Yang et al. JOURNAL OF IMMUNOLOGY
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma
- (2009) F. Zhao et al. CLINICAL CANCER RESEARCH
- Targeting dendritic cell signaling to regulate the response to immunization
- (2008) D. Escors et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started